NKT cells play a limited role in the neutrophilic inflammatory responses and host defense to pulmonary infection with Pseudomonas aeruginosa

Microbes and Infection

Volumn 8, Issue 12-13, 2006, Pages 2679-2685

  Kinjo, Takeshi ^a   Nakamatsu, Masashi ^a   Nakasone, Chikara ^a   Yamamoto, Natsuo ^a   Kinjo, Yuki ^a   Miyagi, Kazuya ^a   Uezu, Kaori ^a   Nakamura, Kiwamu ^a,d   Higa, Futoshi ^a   Tateyama, Masao ^a   Takeda, Kazuyoshi ^b   Nakayama, Toshinori ^c   Taniguchi, Masaru ^d   Kaku, Mitsuo ^e,f,g   Fujita, Jiro ^a   Kawakami, Kazuyoshi ^g,h  

^a UNIVERSITY OF THE RYUKYUS   (Japan)

^b JUNTENDO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^c CHIBA UNIVERSITY   (Japan)

^d RIKEN Center for Integrative Medical Sciences   (Japan)

^e Laboratory Diagnostics   (Japan)

^f CRESCENDO ^*  (Japan)

^g TOHOKU UNIVERSITY HOSPITAL   (Japan)

^h School of Health Sciences   (Japan)

Author keywords

Host defense; MIP 2; Neutrophils; NKT cells; Pseudomonas aeruginosa; Streptococcus pneumoniae; TNF

Indexed keywords

ALPHA GALACTOSYLCERAMIDE; GAMMA INTERFERON; GAMMA INTERFERON ANTIBODY; MACROPHAGE INFLAMMATORY PROTEIN 2; RECOMBINANT GAMMA INTERFERON; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; GRAM NEGATIVE INFECTION; HOST RESISTANCE; INFLAMMATION; KNOCKOUT MOUSE; LUNG INFECTION; MOUSE; MOUSE STRAIN; NATURAL KILLER T CELL; NEUTROPHIL COUNT; NONHUMAN; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA; STATISTICAL SIGNIFICANCE; SYNTHESIS;

ANIMALS; CELL COUNT; CHEMOKINES; GALACTOSYLCERAMIDES; IMMUNOLOGIC FACTORS; INFLAMMATION; INTERFERON TYPE II; KILLER CELLS, NATURAL; LUNG; LYMPHOCYTE SUBSETS; MICE; MICE, KNOCKOUT; NEUTROPHILS; PNEUMONIA, BACTERIAL; PSEUDOMONAS AERUGINOSA; PSEUDOMONAS INFECTIONS; T-LYMPHOCYTES; TUMOR NECROSIS FACTOR-ALPHA;

BACTERIA (MICROORGANISMS); PSEUDOMONAS AERUGINOSA; STREPTOCOCCUS PNEUMONIAE;

EID: 33751079376     PISSN: 12864579     EISSN: 1769714X     Source Type: Journal    
DOI: 10.1016/j.micinf.2006.07.016     Document Type: Article

References (29)

1. Pier G.B. Pulmonary disease associated with Pseudomonas aeruginosa in cystic fibrosis: current status of the host-bacterium interaction. J. Infect. Dis. 151 (1985) 575-580
2. Keicho N., and Kudoh S. Diffuse panbronchiolitis: role of macrolides in therapy. Am. J. Respir. Med. 1 (2002) 119-131
3. Gould I.M., and Wise R. Pseudomonas aeruginosa: clinical manifestations and management. Lancet 2 8466 (1985) 1224-1227
4. Bodey G.P., Bolivar R., Fainstein V., and Jadeja L. Infections caused by Pseudomonas aeruginosa. Rev. Infect. Dis. 5 (1983) 279-313
5. Musher D., Cohen M., and Baker C. Immune responses to extracellular bacteria. In: Rich R.R., Fleisher T.A., Schwartz B.D., Shearer W.T., and Strober W. (Eds). Clinical Immunology. Principles and Practice (1996), Mosby-Year Book, Inc., St. Louis, MO 479-492
6. Doring G. Host response to Pseudomonas aeruginosa. Acta Paediatr. Scand. Suppl. 363 (1989) 37-39
7. Kadioglu A., and Andrew P.W. The innate immune response to pneumococcal lung infection: the untold story. Trends Immunol. 25 (2004) 143-149
8. Toews G.B., Hansen E.J., and Strieter R.M. Pulmonary host defenses and oropharyngeal pathogens. Am. J. Med. 88 (1990) 20S-24S
9. Mizgerd J.P. Molecular mechanisms of neutrophil recruitment elicited by bacteria in the lungs. Semin. Immunol. 14 (2002) 123-132
10. Taniguchi M., Harada M., Kojo S., Nakayama T., and Wakao H. The regulatory role of Valpha14 NKT cells in innate and acquired immune response. Annu. Rev. Immunol. 21 (2003) 483-513
11. Kronenberg M. Toward an understanding of NKT cell biology: progress and paradoxes. Annu. Rev. Immunol. 23 (2005) 877-900
12. Kinjo Y., and Kronenberg M. Valpha14i NKT cells are innate lymphocytes that participate in the immune response to diverse microbes. J. Clin. Immunol. 25 (2005) 522-533
13. Kawakami K., Yamamoto N., Kinjo Y., Miyagi K., Nakasone C., Uezu K., Kinjo T., Nakayama T., Taniguchi M., and Saito A. Critical role of Valpha14+ natural killer T cells in the innate phase of host protection against Streptococcus pneumoniae infection. Eur. J. Immunol. 33 (2003) 3322-3330
14. Nieuwenhuis E.E., Matsumoto T., Exley M., Schleipman R.A., Glickman J., Bailey D.T., Corazza N., Colgan S.P., Onderdonk A.B., and Blumberg R.S. CD1d-dependent macrophage-mediated clearance of Pseudomonas aeruginosa from lung. Nat. Med. 8 (2002) 588-593
15. Godfrey D.I., MacDonald H.R., Kronenberg M., Smyth M.J., and Kaer L.V. NKT cells: what's in a name?. Nat. Rev. Immunol. 4 (2004) 231-237
16. Kawano T., Cui J., Koezuka Y., Toura I., Kaneko Y., Motoki K., Ueno H., Nakagawa R., Sato H., Kondo E., Koseki H., and Taniguchi M. CD1d-restricted and TCR-mediated activation of Valpha14 NKT cells by glycosylceramides. Science 278 (1997) 1626-1629
17. Seino K., Fujii S., Harada M., Motohashi S., Nakayama T., Fujisawa T., and Taniguchi M. Valpha14 NKT cell-mediated anti-tumor responses and their clinical application. Springer Semin. Immun. 27 (2005) 65-74
18. Terabe M., and Berzofsky J.A. Immunoregulatory T cells in tumor immunity. Curr. Opin. Immunol. 16 (2004) 157-162
19. Kawano T., Cui J., Koezuka Y., Toura I., Kaneko Y., Sato H., Kondo E., Harada M., Koseki H., Nakayama T., Tanaka Y., and Taniguchi M. Natural killer-like non-specific tumor cell lysis mediated by specific ligand-activated Valpha14 NKT cells. Proc. Natl. Acad. Sci. U.S.A. 95 (1998) 5690-5693
20. Mendiratta S.K., Martin W.D., Hong S., Boesteanu A., Joyce S., and Van Kaer L. CD1d1 mutant mice are deficient in natural T cells that promptly produce IL-4. Immunity 6 (1997) 469-477
21. Kitamura H., Iwakabe K., Yahata T., Nishimura S., Ohta A., Ohmi Y., Sato M., Takeda K., Okumura K., van Kaer L., Kawano T., Taniguchi M., and Nishimura T. The natural killer T (NKT) cell ligand alpha-galactosylceramide demonstrates its immunopotentiating effect by inducing interleukin (IL)-12 production by dendritic cells and IL-12 receptor expression on NKT cells. J. Exp. Med. 189 (1999) 1121-1128
22. Kobayashi E., Motoki M., Uchida T., Fukushima H., and Koezuka Y. KRN7000, a novel immunomodulator, and its antitumor activities. Oncol. Res. 7 (1995) 529-534
23. Jones M.R., Simms B.T., Lupa M.M., Kogan M.S., and Mizgerd J.P. Lung NF-kappaB activation and neutrophil recruitment require IL-1 and TNF receptor signaling during pneumococcal pneumonia. J. Immunol. 175 (2005) 7530-7535
24. Rijneveld A.W., van den Dobbelsteen G.P., Florquin S., Standiford T.J., Speelman P., van Alphen L., and van der Poll T. Roles of interleukin-6 and macrophage inflammatory protein-2 in pneumolysin-induced lung inflammation in mice. J. Infect. Dis. 185 (2002) 123-126
25. Lee J., Sorbo L.D., Khine A.A., de Azavedo J., Low D.E., Bell D., Uhlig S., Slutsky A.S., and Zhang H. Modulation of bacterial growth by tumor necrosis factor-alpha in vitro and in vivo. Am. J. Respir. Crit. Care Med. 168 (2003) 1462-1470
26. Tsai W.C., Strieter R.M., Mehrad B., Newstead M.W., Zeng X., and Standiford T.J. CXC chemokine receptor CXCR2 is essential for protective innate host response in murine Pseudomonas aeruginosa pneumonia. Infect. Immun. 68 (2000) 4289-4296
27. Duthie M.S., Kahn M., White M., Kapur R.P., and Kahn S.J. Critical proinflammatory and anti-inflammatory functions of different subsets of CD1d-restricted natural killer T cells during Trypanosoma cruzi infection. Infect. Immun. 73 (2005) 181-192
28. Chackerian A., Alt J., Perera V., and Behar S.M. Activation of NKT cells protects mice from tuberculosis. Infect. Immun. 70 (2002) 6302-6309
29. Schultz M.J., Rijneveld A.W., Speelman P., van Deventer S.J., and van der Poll T. Endogenous interferon-gamma impairs bacterial clearance from lungs during Pseudomonas aeruginosa pneumonia. Eur. Cytokine. Netw. 12 (2001) 39-44